The Indonesia Diabetes Care Drugs Market is expected to reach USD 301.55 million in 2024 and grow at a CAGR of 4.20% to reach USD 370.43 million by 2029. Eli Lilly, Boehringer Ingelheim, Sanofi, Novo Nordisk and AstraZeneca are the major companies operat
5.3.5.3 Rest of South America 6. COMPETITIVE LANDSCAPE 6.1 Company Profiles 6.1.1 DAIICHI SANKYO COMPANY, LIMITED 6.1.2 Astrazeneca 6.1.3 Cadila Pharmaceuticals 6.1.4 Sun Pharmaceutical Industries Ltd. 6.1.5 Teva Pharmaceutical Industries Ltd. ...
The brain tumor drugs market size was valued at USD 1.80 billion in 2022 and is projected to grow USD 1.89 billion in 2023 to USD 3.72 billion by 2030, exhibiting a CAGR of 10.2% during the forecast period. Moreover, theU.S. brain tumor drugsmarket is projected to grow significantly, r...
For teams of up to 5 people $959 USD per month, billed annually1 Buy now Free + Premium Statistics Reports Market Insights 1All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price. ...
, Alder BioPharmaceuticals Inc., Amgen Inc., Astellas Pharma India Private Limited, AstraZeneca, Dr. Reddy's Laboratories Ltd., Johnson & Johnson Services, Inc, Eisai Co., Ltd., Eli Lilly and Company, Bayer AGSitemap., CoLucid, KOWA Pharmaceuticals America, Inc., Luitpold Pharmaceuticals, ...
For instance, in June 2023 , AstraZeneca announce the launch of IMJUDO, a revolutionary cancer medication that marks a significant advancement in cancer treatment, for patients in the United Arab Emirates (UAE). However, the patent expiry of branded drugs and entry of generic drugs into the ma...
In September 2022, AstraZeneca and Merck jointly declared that Lynparza (olaparib) had received approval in China for the maintenance treatment of adult patients diagnosed with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer. This approval applies specifically to patients who ...
Major players operating in the global pulmonary drug delivery systems market include 3M Health Care, Allied Healthcare Products, Inc., AstraZeneca, Boehringer Ingelheim International GmbH., CareFusion Corporation, GF Health Products, Inc., GlaxoSmithKline plc, Merck & Co., Inc., Novartis AG, Omron...
Key Players Mentioned in the Global Constipation Treatment Market Research Report: , Takeda, SGYP, Sucampo Pharmaceuticals, Ironwood Pharmaceuticals, Abbott, AstraZeneca, Cosmo Pharmaceuticals, Sanofi, Daewoong, Bayer, Prestige Brands, Janssen Pharmaceutical, Shionogi, Albireo Pharma, Renexxion...
Key Companies ProfiledKirin Holdings Company Limited; Vericel Corporation; Mereo Biopharma Group plc; Novartis AG; AM-Pharma B.V.; Bayer AG; Pfizer Inc.; Ultragenyx Pharmaceutical Inc.; BioMarin Pharmaceutical Inc.; Prior Company Ltd.; Enobia Pharma Corporation; AstraZeneca plc; Rallybio Corporati...